ArticleSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition2026
[Association Between Blood Routine Index and Metabolic Syndrome in High-altitude Tibetan Population].
Article in Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the relationship between blood routine indicators and the prevalence of metabolic syndrome (MetS) and its risk factors in the Tibetan population in Xizang. Methods: From August 2021 to August 2023, a multi-stage stratified cluster random sampling method was used to conduct a questionnaire survey, anthropometric measurements, and laboratory examinations of the Tibetan population in the Lhasa, Ali, and Naqu areas of Xizang. A total of 2 832 people were included in the study. After adjusting for potential confounding factors, logistic regression analysis was used to examine the correlation between blood routine indicators and MetS. Results: The prevalence of MetS was 11.5%, with rates of 12.9% among males and 10.6% among females. After adjusting for confounding factors, white blood cell count (WBC), hemoglobin (Hb), hematocrit (HCT), and platelet distribution width (PDW) were associated with MetS prevalence. Compared with the lowest tertile (Q1), the odds ratios (ORs) for Q2 and Q3 of WBC were 1.629 (95% CI: 1.164-2.279, Conclusion: WBC, Hb, HCT, and PDW in the complete blood count were associated with the prevalence of MetS, WBC and HCT were risk factors for the prevalence of MetS, while Hb and PDW were protective factors. It is recommended that complete blood counts be included in the monitoring and management of metabolic diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.